DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Left Ventricular Assist Device (LVAD) Market - Global Industry Analysis, Size, Share, Trends and Forecast, 2014-2022" report to their offering.
The market for LVAD is expected to reach around USD 1.9 billion by 2022, growing at a CAGR of 17.3% during the forecast period of 2016e to 2022f.
However, there are certain restraining factors which could hamper the growth of the market, which includes, high costs associated with the LAVD implantation compared to other therapies available for CVD diseases.
Geographically, North America is leading contributor to the market and is expected to retain its position during the forecast period. Nonetheless, the market for Asia-Pacific region is expected to grow at a faster rate owing to increasing prevalence of CVD diseases, growing awareness among the population, improving healthcare infrastructure, rise in healthcare spending, and favorable government policies.
The company profile section include detailed analysis of some of the key players such as:
- Apaxis Inc.
- Berlin Heart GmbH
- Heart Ware International Inc.
- Jarvik Heart Inc.
- St Jude Medical
Key Topics Covered:
- Scope of the report
- Executive summary
- Qualitative analysis
Global LVAD market, by type of indication, 2014-2022f
Global LVAD market, by geography, 2014-2022f
- Company profiles
For more information about this report visit http://www.researchandmarkets.com/research/4zbbvn/left_ventricular